US Stock MarketDetailed Quotes

MRKR Marker Therapeutics

Watchlist

4.3650
-0.0350-0.80%

Close Apr 25 16:00 ET

38.86MMarket Cap-4643P/E (TTM)

Marker Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

51.93%-10.34M

43.84%-2.3M

83.47%-867.18K

-2,158.86%-1.28M

51.84%-5.89M

21.14%-21.51M

15.53%-4.1M

30.39%-5.25M

100.92%62.22K

-50.94%-12.23M

Net income from continuing operations

28.97%-14.05M

9.96%-2.74M

47.93%-2.98M

-206.41%-3.36M

49.88%-4.97M

52.78%-19.78M

68.83%-3.04M

53.93%-5.73M

89.96%-1.1M

-12.88%-9.91M

Depreciation and amortization

----

16.48%971.73K

----

10.59%834.22K

Other non cash items

----

---278.68K

--0

----

Change In working capital

159.76%2.85M

120.24%292.11K

1,202.48%1.94M

93.58%3.17M

46.61%-2.55M

-187.05%-4.76M

-155.12%-1.44M

-106.71%-175.94K

-2.98%1.64M

-229.21%-4.78M

-Change in receivables

157.22%1.37M

-31.00%-944.5K

257.85%1.66M

153.85%336.79K

16,481.83%319.12K

-340.10%-2.4M

-12,016,516.67%-720.99K

-2,449,844.19%-1.05M

-162.51%-625.44K

-532.47%-1.95K

-Change in prepaid assets

726.82%861.11K

205.23%941.23K

50.53%158.11K

59.08%-244.56K

-97.80%6.34K

124.41%104.15K

42.31%308.37K

4.54%105.03K

28.75%-597.66K

203.59%288.41K

-Change in payables and accrued expense

146.32%611.26K

139.10%402.91K

-98.53%11.32K

-84.54%447.05K

93.68%-250.02K

-131.87%-1.32M

-173.65%-1.03M

-70.67%772.41K

81.83%2.89M

-166.71%-3.95M

-Change in other current liabilities

----

14.00%-127.8K

----

-131.02%-148.61K

-Change in other working capital

----

-159.25%-2.5M

-200.00%-1.15M

--0

---181.86K

---964.32K

Cash from discontinued investing activities

-11.73%-6.1M

97.14%-62.94K

89.15%-260.28K

-5.46M

-2.2M

-2.4M

Operating cash flow

39.05%-16.44M

62.45%-2.37M

85.25%-1.13M

-787.95%-7.06M

51.84%-5.89M

1.13%-26.97M

-29.79%-6.31M

-1.46%-7.65M

88.29%-794.71K

-50.94%-12.23M

Investing cash flow

Cash flow from continuing investing activities

95.41%-112.61K

-75.00%-2.45M

Net PPE purchase and sale

----

95.41%-112.61K

----

-75.00%-2.45M

Cash from discontinued investing activities

Investing cash flow

477.42%18.66M

--0

928.54%18.78M

95.41%-112.61K

-57.93%-4.95M

63.60%-127.34K

89.86%-99.37K

-466.88%-2.27M

-75.00%-2.45M

Financing cash flow

Cash flow from continuing financing activities

446.74%1.11M

-96.29%5.14K

479.27K

-98.84%736

619.97K

-99.62%202.13K

138.56K

163.10%63.57K

Net common stock issuance

401.97%1.01M

--0

--394.67K

--0

--619.97K

-99.62%202.13K

--138.56K

--0

161.23%63.57K

--0

Proceeds from stock option exercised by employees

--90.48K

--5.14K

--84.61K

----

--0

----

Cash from discontinued financing activities

Financing cash flow

446.74%1.11M

-96.29%5.14K

--479.27K

-98.84%736

--619.97K

-99.62%202.13K

--138.56K

--0

163.10%63.57K

--0

Net cash flow

Beginning cash position

-72.91%11.78M

-3.33%17.47M

-29.82%18.12M

-77.79%6.4M

-72.91%11.78M

103.71%43.5M

-62.89%18.08M

-54.87%25.82M

-55.32%28.82M

103.71%43.5M

Current changes in cash

110.50%3.33M

62.47%-2.36M

91.63%-648.19K

491.04%11.72M

63.34%-5.38M

-243.22%-31.72M

-20.86%-6.29M

9.05%-7.75M

58.86%-3M

-134.01%-14.68M

End cash Position

28.26%15.11M

-3.33%17.47M

-29.82%18.12M

-77.79%6.4M

-72.91%11.78M

-62.89%18.08M

-54.87%25.82M

-55.32%28.82M

Free cash flow

39.05%-16.44M

62.45%-2.37M

85.25%-1.13M

-518.95%-6.94M

59.12%-6M

11.31%-26.97M

-21.07%-6.31M

10.22%-7.65M

123.07%1.66M

-54.49%-14.68M

Currency Unit

USD

Accounting Standards

US-GAAP

	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	51.93%-10.34M	43.84%-2.3M	83.47%-867.18K	-2,158.86%-1.28M	51.84%-5.89M	21.14%-21.51M	15.53%-4.1M	30.39%-5.25M	100.92%62.22K	-50.94%-12.23M
Net income from continuing operations	28.97%-14.05M	9.96%-2.74M	47.93%-2.98M	-206.41%-3.36M	49.88%-4.97M	52.78%-19.78M	68.83%-3.04M	53.93%-5.73M	89.96%-1.1M	-12.88%-9.91M
Depreciation and amortization	----	----	----	----	16.48%971.73K	----	----	----	----	10.59%834.22K
Other non cash items	----	----	----	----	----	---278.68K	--0	----	----	----
Change In working capital	159.76%2.85M	120.24%292.11K	1,202.48%1.94M	93.58%3.17M	46.61%-2.55M	-187.05%-4.76M	-155.12%-1.44M	-106.71%-175.94K	-2.98%1.64M	-229.21%-4.78M
-Change in receivables	157.22%1.37M	-31.00%-944.5K	257.85%1.66M	153.85%336.79K	16,481.83%319.12K	-340.10%-2.4M	-12,016,516.67%-720.99K	-2,449,844.19%-1.05M	-162.51%-625.44K	-532.47%-1.95K
-Change in prepaid assets	726.82%861.11K	205.23%941.23K	50.53%158.11K	59.08%-244.56K	-97.80%6.34K	124.41%104.15K	42.31%308.37K	4.54%105.03K	28.75%-597.66K	203.59%288.41K
-Change in payables and accrued expense	146.32%611.26K	139.10%402.91K	-98.53%11.32K	-84.54%447.05K	93.68%-250.02K	-131.87%-1.32M	-173.65%-1.03M	-70.67%772.41K	81.83%2.89M	-166.71%-3.95M
-Change in other current liabilities	----	----	----	----	14.00%-127.8K	----	----	----	----	-131.02%-148.61K
-Change in other working capital	----	----	----	----	-159.25%-2.5M	-200.00%-1.15M	--0	--0	---181.86K	---964.32K
Cash from discontinued investing activities	-11.73%-6.1M	97.14%-62.94K	89.15%-260.28K			-5.46M	-2.2M	-2.4M
Operating cash flow	39.05%-16.44M	62.45%-2.37M	85.25%-1.13M	-787.95%-7.06M	51.84%-5.89M	1.13%-26.97M	-29.79%-6.31M	-1.46%-7.65M	88.29%-794.71K	-50.94%-12.23M
Investing cash flow
Cash flow from continuing investing activities					95.41%-112.61K					-75.00%-2.45M
Net PPE purchase and sale	----	----	----	----	95.41%-112.61K	----	----	----	----	-75.00%-2.45M
Cash from discontinued investing activities
Investing cash flow	477.42%18.66M	--0	--0	928.54%18.78M	95.41%-112.61K	-57.93%-4.95M	63.60%-127.34K	89.86%-99.37K	-466.88%-2.27M	-75.00%-2.45M
Financing cash flow
Cash flow from continuing financing activities	446.74%1.11M	-96.29%5.14K	479.27K	-98.84%736	619.97K	-99.62%202.13K	138.56K	0	163.10%63.57K	0
Net common stock issuance	401.97%1.01M	--0	--394.67K	--0	--619.97K	-99.62%202.13K	--138.56K	--0	161.23%63.57K	--0
Proceeds from stock option exercised by employees	--90.48K	--5.14K	--84.61K	----	----	--0	--0	--0	----	----
Cash from discontinued financing activities
Financing cash flow	446.74%1.11M	-96.29%5.14K	--479.27K	-98.84%736	--619.97K	-99.62%202.13K	--138.56K	--0	163.10%63.57K	--0
Net cash flow
Beginning cash position	-72.91%11.78M	-3.33%17.47M	-29.82%18.12M	-77.79%6.4M	-72.91%11.78M	103.71%43.5M	-62.89%18.08M	-54.87%25.82M	-55.32%28.82M	103.71%43.5M
Current changes in cash	110.50%3.33M	62.47%-2.36M	91.63%-648.19K	491.04%11.72M	63.34%-5.38M	-243.22%-31.72M	-20.86%-6.29M	9.05%-7.75M	58.86%-3M	-134.01%-14.68M
End cash Position	28.26%15.11M	28.26%15.11M	-3.33%17.47M	-29.82%18.12M	-77.79%6.4M	-72.91%11.78M	-72.91%11.78M	-62.89%18.08M	-54.87%25.82M	-55.32%28.82M
Free cash flow	39.05%-16.44M	62.45%-2.37M	85.25%-1.13M	-518.95%-6.94M	59.12%-6M	11.31%-26.97M	-21.07%-6.31M	10.22%-7.65M	123.07%1.66M	-54.49%-14.68M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall